A new alliance between MakroCare and LSK Global Pharmaceutical Services offers a single entry point to a range of drug development and commercialization services in key Asian markets as well as the US, according to PharmaTimes.

MakroCare’s home base is Hyderabad, India and LSK Global’s headquarters are in Seoul, Korea. Both are active in the US and various European markets, while MakroCare also has a presence in Western Europe.

The alliance agreement enables the two companies to offer a broad spread of services to pharmaceutical, biotechnology and medical device companies in key Asian territories, MakroCare said.